Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott’s Xience V Drives Fourth-Quarter Vascular Sales Up 60%

Jan 26 2009

Related Content

Xience V / Promus Drug-Eluting Stent Is Off And Running On U.S. Market

Jul 07 2008

Abbott’s Eye On Diversity Leads To $2.8 Bil. Advanced Medical Optics Buy

Jan 19 2009

Additional Topics

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window